Completed OBSERVATIONAL NCT01481207

Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy

Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy

Sponsor: University Children's Hospital, Zurich

Conditions Hypoxic Ischemic Encephalopathy

Updated 8 times since 2017 Last updated: Sep 24, 2019 Started: Sep 30, 2011 Primary completion: Jul 9, 2019 Completion: Jul 9, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01481207, this observational or N/A phase trial focuses on Hypoxic Ischemic Encephalopathy and remains completed. Sponsored by University Children's Hospital, Zurich, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2019 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Children's Hospital, Zurich

Data source: University Children's Hospital, Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland